Sign in to view content

6-Month Results of a Phase 1b-2 Prospective Multicenter Clinical Trial of a Novel Targeted Therapy (AU-011) for the Treatment of Choroidal Melanoma

Amy C. Schefler, MD FACS FASRS

Video
Published 2018

Related

Year 1 Time to Mobility Test Completion in a Voretigene Neparvovec-rzyl Trial in Subjects With RPE65 Mutation–Associated Inherited Retinal Disease
Julia A. Haller, MD
On Demand Cases, Courses, and Papers
2018
Episode 5: Adding Dexamethasone Implant to Ranibizumab for Persistent DME with Dr. Raj Maturi
Keyvan Koushan, MD, FRCSC
Member Podcasts
2017
SCORE2 Month 6 to Month 12 Results: 12 Month Outcomes of Treatment Change among Poor Responders at Month 6
Michael S. Ip, MD
Annual Meeting Talks
2018

Category: Ocular Oncology

See more